Literature DB >> 11083863

A conformational intermediate between the resting and desensitized states of the nicotinic acetylcholine receptor.

S E Ryan1, M P Blanton, J E Baenziger.   

Abstract

The structural changes induced in the nicotinic acetylcholine receptor by two noncompetitive channel blockers, proadifen and phencyclidine, have been studied by infrared difference spectroscopy and using the conformationally sensitive photoreactive noncompetitive antagonist 3-(trifluoromethyl)-3-m-([(125)I]iodophenyl)diazirine. Simultaneous binding of proadifen to both the ion channel pore and neurotransmitter sites leads to the loss of positive markers near 1663, 1655, 1547, 1430, and 1059 cm(-)(1) in carbamylcholine difference spectra, suggesting the stabilization of a desensitized conformation. In contrast, only the positive markers near 1663 and 1059 cm(-)(1) are maximally affected by the binding of either blocker to the ion channel pore suggesting that the conformationally sensitive residues vibrating at these two frequencies are stabilized in a desensitized-like conformation, whereas those vibrating near 1655 and 1430 cm(-)(1) remain in a resting-like state. The vibrations at 1547 cm(-)(1) are coupled to those at both 1663 and 1655 cm(-)(1) and thus exhibit an intermediate pattern of band intensity change. The formation of a structural intermediate between the resting and desensitized states in the presence of phencyclidine is further supported by the pattern of 3-(trifluoromethyl)-3-m-([(125)I]iodophenyl)diazirine photoincorporation. In the presence of phencyclidine, the subunit labeling pattern is distinct from that observed in either the resting or desensitized conformations; specifically, there is a concentration-dependent increase in the extent of photoincorporation into the delta-subunit. Our data show that domains of the nicotinic acetylcholine receptor interconvert between the resting and desensitized states independently of each other and suggest a revised model of channel blocker action that involves both low and high affinity agonist binding conformational intermediates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083863     DOI: 10.1074/jbc.M007063200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.

Authors:  Judith A Heiny; Violetta V Kravtsova; Frederic Mandel; Tatiana L Radzyukevich; Boubacar Benziane; Alexander V Prokofiev; Steen E Pedersen; Alexander V Chibalin; Igor I Krivoi
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

2.  Alteration of sugar-induced conformational changes of the melibiose permease by mutating Arg141 in loop 4-5.

Authors:  Xavier León; Gérard Leblanc; Esteve Padrós
Journal:  Biophys J       Date:  2009-06-17       Impact factor: 4.033

3.  Role of glycosylation and membrane environment in nicotinic acetylcholine receptor stability.

Authors:  Corrie J B daCosta; Daniel E E Kaiser; John E Baenziger
Journal:  Biophys J       Date:  2004-12-30       Impact factor: 4.033

4.  A lipid-dependent uncoupled conformation of the acetylcholine receptor.

Authors:  Corrie J B daCosta; John E Baenziger
Journal:  J Biol Chem       Date:  2009-04-08       Impact factor: 5.157

5.  The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms.

Authors:  Guillermo Spitzmaul; Fernanda Gumilar; James P Dilger; Cecilia Bouzat
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

6.  Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector.

Authors:  Selvanayagam Nirthanan; Galo Garcia; David C Chiara; S Shaukat Husain; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

7.  Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain.

Authors:  Deqiang Zhang; Justin Gullingsrud; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.